Finally, survival analysis using Kaplan-Meier (KM) estimates indicated that elevated SDHB expression was correlated with a shorter five-year survival rate in 718 lung adenocarcinoma patients (HR = 1.53, p < 0.000, Figure 3I). Here, SDHB is linked to lung adenocarcinoma.